-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
| Chinese experts successfully explored fewer and more precise single-hole robotic lung cancer surgery |
China News Service, April 9th (Chen Jing Yao Jun) Robotic surgery is the most cutting-edge technology in minimally invasive thoracic surgery in the world today, which can provide patients with safer, thorough, accurate and fast surgery.
Currently, clinical robotic chest surgery usually requires 3 or 4 incisions.
Professor Luo Qingquan’s team proposed a single-hole operation technique of “crossing robotic arms and swapping left and right hands”, effectively avoiding the technical bottleneck of robot “arms” interfering with each other under a single incision, and realizing a single-port-multi-arm robotic chest surgery process , To reduce the trauma to a lower level, and make minimally invasive more "minimally invasive".
The hospital told reporters that the relevant technical application papers of Professor Luo Qingquan’s team were recently published online in the well-known journal Translational Lung Cancer Research.
This innovative paper introduces the right lower lobectomy performed by Luo Qingquan’s team using a single-port incision under the "porous robotic system".
It is understood that in 2009, Professor Luo Qingquan from Shanghai Chest Hospital led the team to complete the robotic lobectomy in China first, opening the application of robotic chest surgery in China.
During the interview, the reporter learned that at present, the imported robotic surgery systems are basically used in clinical practice by Chinese medical institutions.
In addition, Professor Luo also took the lead in research topics related to emerging cutting-edge technologies, discussed broadening the indications of robotic surgery, formulated and updated clinical guidelines and expert consensus, and brought more senior patients, young patients, or patients with special comorbidities More and more precise treatment options.
However, Professor Luo Qingquan said bluntly: "Although we are now promoting minimally invasive surgery, we continue to minimize surgical trauma.
It is reported that in the future, the Shanghai Thoracic Hospital team will actively explore the application of 5G technology in the remote operation of robotic surgery, and carry out research on difficult robotic features such as locally advanced lung cancer, thymic epithelial tumors, and locally advanced esophageal cancer.
